Evidence-Based Medicine Guidelines
Dornase alfa for cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dornase Alfa for Cystic Fibrosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452992/all/Dornase_alfa_for_cystic_fibrosis.
Dornase alfa for cystic fibrosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/452992/all/Dornase_alfa_for_cystic_fibrosis. Accessed November 24, 2024.
Dornase alfa for cystic fibrosis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452992/all/Dornase_alfa_for_cystic_fibrosis
Dornase Alfa for Cystic Fibrosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452992/all/Dornase_alfa_for_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dornase alfa for cystic fibrosis
ID - 452992
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452992/all/Dornase_alfa_for_cystic_fibrosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
